Concussion in Motor Vehicle Accidents: The Concussion Identification Index
NCT ID: NCT02858544
Last Updated: 2016-08-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1790 participants
OBSERVATIONAL
2013-11-30
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Objective Brain Function Assessment of mTBI/Concussion
NCT03963804
Validation of Brain Function Assessment Algorithm for mTBI/Concussion
NCT03671083
Evaluating a Novel Method of EEG Evoked Response Potential Analysis in Concussion Assessment
NCT03265912
Understanding Concussion/Mild Traumatic Brain Injury
NCT03381638
Objective Brain Function Assessment of mTBI/Concussion in High School Athletes
NCT02661633
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Cohort 1 is the validation group and will be used to confirm the optimal cut-off score of the Concussion Identification Index (CIDI) with the score on the ImPACT.
Cohort 2 is the cross-validation group.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group1 - Validation Group
n=890 patients seen and evaluated for possible concussion after a motor vehicle accident. Patients with qualifying scores on the Concussion Identification Index will also complete the ImPACT.
The Concussion Identification Index
Patient completion of the Concussion Identification Index, a report of crash characteristics, injuries sustained, and post-accident neurological signs and symptoms
ImPACT
Patient- completed computerized neurocognitive test battery
Group 2 - Cross Validation Group
n=900 patients seen and evaluated for possible concussion after a motor vehicle accident. Patients with qualifying scores on the Concussion Identification Index will also complete the ImPACT.
The Concussion Identification Index
Patient completion of the Concussion Identification Index, a report of crash characteristics, injuries sustained, and post-accident neurological signs and symptoms
ImPACT
Patient- completed computerized neurocognitive test battery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
The Concussion Identification Index
Patient completion of the Concussion Identification Index, a report of crash characteristics, injuries sustained, and post-accident neurological signs and symptoms
ImPACT
Patient- completed computerized neurocognitive test battery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients who presented for initial evaluation of injuries greater than 90 days after MVA occurred
* Patients who declined to take a computerized neurocognitive test battery
* Patients who were not fluent in either English or Spanish
10 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Clionsky Neuro Systems Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mitchell I Clionsky, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Clionsky Neuro Systems Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clionsky Neuro Systems, Inc.
Springfield, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C-MVA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.